Jf. Doane et al., RELATION OF VISUAL SYMPTOMS TO TOPOGRAPHIC ABLATION ZONE DECENTRATIONAFTER EXCIMER-LASER PHOTOREFRACTIVE KERATECTOMY, Ophthalmology, 102(1), 1995, pp. 42-47
Background: The authors used computer-assisted videokeratoscopy to ana
lyze the relation of photorefractive keratectomy ablation zone decentr
ation to subjective patient assessments of disturbing visual symptoms.
Methods: Ablation zone decentration was measured 1 month postoperativ
ely. The study population was divided into two groups: group 1, patien
ts whose ablation zone decentrations were less than 0.50 mm; group 2,
patients whose ablation zone decentrations were greater than 0.50 mm.
Visual symptoms including glare, rings or halos around lights and prob
lems with night driving were scored preoperatively and 6 months postop
eratively. The Hotelling T-square and chi-square tests were used. Resu
lts: The mean decentration from the center of the ablation zone to the
pupillary center was 0.30 mm and 190 degrees for group 1 compared wit
h 0.66 mm and 198 degrees for group 2. The Hotelling T-square test sho
wed a significant statistical preoperative/postoperative difference in
group 1 (P < 0.03) for the halo symptom category. No other symptom ca
tegory showed a significant statistical difference in either group for
the mean scores. The Hotelling T-square test did not show a statistic
ally significant difference between the two groups preoperatively to p
ostoperatively regarding the mean scores of the individual patient dif
ferences for the three symptoms. The only significant statistical diff
erence for the individual patient ratings preoperatively to postoperat
ively was for the halo symptom category (chi-square = 7.756; P < 0.03)
. Conclusions: Multivariate analysis did not show a significant statis
tical difference preoperatively between the two groups or postoperativ
ely except for group 1 with regard to the halo symptom category. It ap
pears from this study that ablation zone decentrations less than 0.89
mm from the pupillary center do not necessarily produce unwanted visua
l symptoms 6 months postoperatively.